Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Entrada Therapeutics Receives Authorization In The EU To Initiate The ELEVATE-45-201 Phase 1/2 Multiple Ascending Dose Clinical Study Of ENTR-601-45 In Patients With Duchenne Muscular Dystrophy Amenable To Exon 45 Skipping

Author: Benzinga Newsdesk | May 28, 2025 07:05am

Posted In: TRDA